MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

NCT00572182 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
33
Enrollment
NETWORK
Sponsor class

Stopped This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.

Conditions

Interventions

Sponsor

Pediatric Brain Tumor Consortium

Collaborators